Litigation Watch: ARTHRITIS DRUGS is a monthly newsletter for attorneys, focusing on drugs used to treat osteo and rheumatoid arthritis: Arava, Enbrel, Remicade, Humira, Vioxx, Celebrex and more. These drugs are already the subject of litigation following claims that they cause everything from liver damage to cancer, heart failure and strokes. Each issue features case news, interviews, legislative and FDA updates, and reviews from current medical literature.
Arthritis Drugs - Issue: 7
Judge Orders Merck to Produce Clinical Trial Studies Database
New Jersey Judge Extends Stay of Order Requiring Merck to Produce Employee Files
New Jersey Woman Sues Pfizer, Claims Bextra Caused Husband's Fatal Heart Attack
Arthritis Drugs - Issue: 6
Abstracts from the Literature - Litigation Watch: Arthritis Drugs - Nov. 2004
After Vioxx Withdrawal, Pfizer Says It Has Plans To Study Bextra, Celebrex
Swiss Researchers Say Vioxx Problems Evident in 2000
Los Angeles Jury Awards $115,000 for Heart Valve Problems Linked to Pondimin
N.J. Supreme Court Declines to Coordinate Celebrex, Remicade and Enbrel Cases
